Key result
Prospective CHAIN-HF registry evaluates regional hub-and-spoke care models in worsening heart failure.
Why the study?
Evidence regarding the multifactorial nature of worsening heart failure and specific barriers in treatment, including advanced therapies, remains scarce despite its high risk of death, rehospitalization, and substantial burden.
Does a structured regional hub-and-spoke collaborative network (CHAIN-HF programme) improve GDMT optimization, referral for advanced HF therapies, and 1-year mortality and hospitalization outcomes in patients with worsening heart failure?
Cohort (n=750)
Yes
Does a structured regional hub-and-spoke collaborative network (CHAIN-HF programme) improve GDMT optimization, referral for advanced HF therapies, and 1-year mortality and hospitalization outcomes in patients with worsening heart failure?
This rationale and design paper establishes the first prospective, dedicated multicentre registry for worsening heart failure across the full ejection fraction spectrum, evaluating both non-medical determinants (such as socio-economic status) and a regional hub-and-spoke collaborative care model.
Answers are grounded in this paper and cite their sources.
Establishes first prospective multicentre worsening HF registry across EF spectrum; leaves open whether hub-and-spoke models improve GDMT and outcomes.
AIMS: Heart failure (HF) is a progressive disease in which periods of clinical stability are interrupted by episodes of clinical deterioration known as worsening heart failure (WHF). Patients who develop WHF are at high risk of subsequent death, rehospitalization, and excessive healthcare costs. As such, WHF could be seen as a separate disease stage and precursor of advanced HF. Whether WHF has a substantial health, societal, and economic impact evidence regarding its multifactorial nature and the specific barriers in treatment, including advanced HF therapies, remains scarce. The CHAIN-HF registry aims to describe the incidence, characteristics, current treatment, and outcomes of WHF. Additionally, it will promote structured regional collaboration and educate on increasing awareness for WHF and describe the implementation of guideline directed medical therapy and utilization of advanced HF therapies in a collaborative network. METHODS AND RESULTS: The CHAIN-HF registry is a prospective, observational, and multicentre study from the collaborating hospitals (Rijnmond HF Network) in the Rotterdam area. Unselected and consecutive patients (irrespective of ejection fraction) with a WHF event will be included. Comprehensive data including demographics, co-morbidities, treatment, and in-hospital and post-discharge outcomes will be collected. Notably, data on socio-economic status, treatment decisions, and referral for advanced HF therapies will be included. CONCLUSIONS: CHAIN-HF will be the first prospective, dedicated WHF registry in a collaborative network of hospitals that will provide robust real-world evidence on the incidence, characteristics, and outcomes of WHF. Moreover, it will provide information on of the value of regional collaboration to improve awareness and outcomes of WHF.
No takes yet. Share an insight, caveat, or question.
Shakoor et al. (2023) conducted a cohort in Worsening heart failure (WHF) with chronic heart failure across the full spectrum of ejection fraction (n=750). Structured regional heart failure collaboration network (CHAIN-HF hub-and-spoke programme) and worsening heart failure clinical management vs. Patients not discussed or included in the CHAIN-HF regional collaborative programme was evaluated on 1-year all-cause mortality, 1-year cardiovascular mortality, number of HF-related hospitalizations (WHF events), and number of referrals for advanced HF therapies. The CHAIN-HF registry is a prospective, multicentre study of at least 750 worsening heart failure patients in the Netherlands designed to evaluate 1-year mortality, hospitalizations, and regional hub-and-spoke care.
Synapse has enriched 10 related papers. Consider them for comparative context: